1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY25 and FY26 cycles referenced as active; specific solicitation deadlines not listed on this hub page — applications submitted via eBRAP portal.
"Peer Reviewed Cancer Research Program (PRCRP)" is currently closed and not accepting applications.
Peer Reviewed Cancer Research Program (PRCRP) is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The PRCRP funds innovative basic, applied, translational, and clinical cancer research to support Service members, Veterans, their families, and the American public.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Peer Reviewed Cancer Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB. DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – Eliminate the burden of cancer.
Mission – To successfully promote research in cancer prevention, detection, treatment, quality of life, and survivorship for Service Members, their families, Veterans, and the » Click on Image to View Summary Sheet Since Fiscal Year 2009 (FY09), the Peer Reviewed Cancer Research Program (PRCRP) has funded innovative basic, applied, translational, and clinical cancer research to support Service members, Veterans, their families, and the American public.
Members of the military are at risk for development of cancer because of their exposure to hazardous environments as part of their duties and deployments. The mission of the PRCRP is to protect and sustain military readiness by promoting high-impact research for cancer prevention, detection, treatment, and survivorship.
To accomplish this, the PRCRP invests in the full spectrum of cancer research from discovery to clinical application, focusing on funding gaps in the research landscape. The PRCRP is a multi-topic research program and has supported over 1100 awards under 33 congressionally-directed topic areas including specific cancer types, groups of cancers, and cancer research areas such as immunology.
The PRCRP topic areas represent 72% of cancer- related medical encounters by active-duty Service Members and their family members 1 . A list of the current PRCRP topic areas is below. A list of historic topic areas is available here.
Pediatric, Adolescent, and Young Adult Cancers 1 Armed Forces Health Surveillance Branch.
MSMR 31, no.6, 2024:8 Congressional Appropriations Topic Areas Offered by Year (FY21-26) Annual Reports to Congress Recent Applications Recommended for Funding FY25 Peer Review Participants The Peer Reviewed Cancer Research Program Researcher and Patient Perspectives [Click on image to watch on DVIDS] The Peer Reviewed Cancer Research Program [Click on image to watch on DVIDS] CDMRP Drives Discovery of New Treatments for Brain Cancers FY25 PRCRP Recommended for Funding List CDMRP Advances AI-Based Metastatic Cancer Detection Through VA Partnerships CDMRP Accelerates Advancements in Cancer Screening for Warfighters, Veterans and the Nation Peer Reviewed Cancer Research Program Booklet Peer Reviewed Cancer Research Program - 18 Cancer-Related Topics in FY24, Including Pediatric Brain Cancer Novel Targets for the Treatment of Metastatic Colorectal Cancer and Survivorship in Cancer Care and Research Novel CAR-T Therapy Targeting BAFF-R Against B-Cell Lymphomas In Her Own Words: Melinda Bachini Speaks about Her Journey with a Rare Cancer and Her Experiences with Living Life to the Fullest A Promising Nanotech Approach to Enhance Immunotherapy in Liver Cancer Annie Horner PRCRP Consumer Reviewer Utilizing a New Orthotopic Xenograft Model of Diffuse Intrinsic Pontine Glioma (DIPG) to Develop Therapeutic Strategies Click here to provide feedback/comments to the PRCRP Last updated Thursday, July 16, 2026
According to the current listing, eligibility includes: Researchers and institutions with projects relevant to cancer, including blood cancers, that align with the program's mission to support military readiness and the health of Service members, Veterans, and the public. Confirm the full requirements in the official notice before applying.
The current listing shows unspecified (Historically funded over 1100 awards). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 30, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Peer Reviewed Cancer Research Program (PRCRP) is funded by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The FY26 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in rare cancers.
Pancreatic Cancer Research Program, Idea Development Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). This award mechanism supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements to accelerate progress in improving outcomes for individuals with pancreatic cancer.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article